elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33567830-CF0EAAFC-F475-4CB1-9288-BCFA6360BC32
Q33567830-CF0EAAFC-F475-4CB1-9288-BCFA6360BC32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33567830-CF0EAAFC-F475-4CB1-9288-BCFA6360BC32
Can denosumab be a substitute, competitor, or complement to bisphosphonates?
P2860
Q33567830-CF0EAAFC-F475-4CB1-9288-BCFA6360BC32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33567830-CF0EAAFC-F475-4CB1-9288-BCFA6360BC32
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5cf09af2d54071c7fa8a6d2c4383216fe2a1bd38
P2860
The pharmacokinetics and pharmacodynamics of denosumab in patients with advanced solid tumours and bone metastases: a systematic review